An HIV-derived nucleoside therapy now treats rare genetic diseases by restoring mitochondrial DNA and improving muscle ...
Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication
Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including ...
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...
A new pre-exposure prophylaxis (PrEP) drug has shown promise as a once-monthly oral pill to help prevent HIV. PrEP plays a key part in reducing the number of new HIV infections by stopping the virus ...
Time magazine has named Czech virologist Tomáš Cihlář among its 100 Most Influential People of 2025, recognising his work on ...
A generation has passed since the world saw the peak in AIDS-related deaths. Those deaths — agonizing, from diseases or infections the body might otherwise fight off — sent loved ones into the streets ...
Drug-related problems in HIV treatment are prevalent, affecting treatment effectiveness and safety, with 99.7% of patients experiencing at least one DRP. Treatment safety was the most frequent problem ...
Drug use, especially injection drug use, presents substantial risks for HIV transmission. Understanding the intricate relationship between drug use and HIV infections is paramount for implementing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback